Therna Biosciences, a biotechnology company pioneering programmable RNA therapeutics, today announced a collaboration with Charles River to advance single-patient RNA medicines for individuals with ...
News-Medical.Net on MSN
Novel gene regulation therapy passes key clinical milestone
Groundbreaking Phase 1/2a clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results